Further evidence for sustained benefits of adalimumab in axSpA
medwireNews,
18-04-2018 | Rheumatology | News | Article medwireNews: Extension results from the ABILITY-1 trial support the long-term…
18-04-2018 | Rheumatology | News | Article medwireNews: Extension results from the ABILITY-1 trial support the long-term…
Action Points Note that this open-label extension study of adalimumab for the treatment of axial spondyloarthritis demonstrated…
Action Points Patients with clinically active axial spondyloarthritis (axSpA), even with high disease activity levels, can lack…
(MedPage Today) -- Patients with axial spondyloarthritis but no spinal x-ray changes benefited from golimumab